<p>(N = 9–11). CT = Control. M05 = Methionine 0.5%. M1 = Methionine 1%. * = <i>p</i>≤0.05 (Tukey's <i>post hoc</i> test) when compared with the CT group at the same period. # = <i>p</i>≤0.05 (Tukey's <i>post hoc</i> test) when compared with the M05 group at the same period. Data are presented as the mean ± SEM.</p
This review presents clinical patterns that should trigger homocysteine measurement in blood, as wel...
Within-person and methodological variability of a given analyte are important elements in determinin...
Homocysteine is a sulfur-containing aminoacid produced during metabolism of methionine. Since 1969 t...
<p>CT = Control. M05 = Methionine 0.5%. M1 = Methionine 1%. (N = 9–11). *<i>p</i> = 0.03 (Tukey's <i...
<p>CT = control; M05 = Methionine 0.5%; M1 = Methionine 1%; Hcy = Homocysteine; Cys = Cysteine; GSH ...
Background: Numerous studies have demonstrated that increased plasma total homocysteine (tHcy), whet...
The toxicity risk of hyperhomocysteinemia is prevented through thiol drug administration which reduc...
<p><b>A.</b> MTT assay of cell viability changes as a function of Hcy concentrations. <b>B.</b> Meas...
<p>Y = 0.002x+0.237, R<sup>2</sup> = 0.313, P = 0.0003 <b>(B)</b> Correlation between basal plasma B...
Hyperhomocysteinaemia is independently associated with atherosclerotic disease. Methionine loading c...
The concentration of free and total homocysteine in plasma increases in time if blood is stored unce...
<p>Total homocysteine levels are higher in individuals with MCI than in controls. HC = healthy contr...
Plasma reduced homocysteine concentrations are increased in end-stage renal disease.BackgroundPlasma...
Hyperhomocysteinemia is a risk factor for vascular disease, although its mechanism of action is not ...
The nonfasting plasma total homocysteine (P-tHcy) concentration was measured in a random sample of 3...
This review presents clinical patterns that should trigger homocysteine measurement in blood, as wel...
Within-person and methodological variability of a given analyte are important elements in determinin...
Homocysteine is a sulfur-containing aminoacid produced during metabolism of methionine. Since 1969 t...
<p>CT = Control. M05 = Methionine 0.5%. M1 = Methionine 1%. (N = 9–11). *<i>p</i> = 0.03 (Tukey's <i...
<p>CT = control; M05 = Methionine 0.5%; M1 = Methionine 1%; Hcy = Homocysteine; Cys = Cysteine; GSH ...
Background: Numerous studies have demonstrated that increased plasma total homocysteine (tHcy), whet...
The toxicity risk of hyperhomocysteinemia is prevented through thiol drug administration which reduc...
<p><b>A.</b> MTT assay of cell viability changes as a function of Hcy concentrations. <b>B.</b> Meas...
<p>Y = 0.002x+0.237, R<sup>2</sup> = 0.313, P = 0.0003 <b>(B)</b> Correlation between basal plasma B...
Hyperhomocysteinaemia is independently associated with atherosclerotic disease. Methionine loading c...
The concentration of free and total homocysteine in plasma increases in time if blood is stored unce...
<p>Total homocysteine levels are higher in individuals with MCI than in controls. HC = healthy contr...
Plasma reduced homocysteine concentrations are increased in end-stage renal disease.BackgroundPlasma...
Hyperhomocysteinemia is a risk factor for vascular disease, although its mechanism of action is not ...
The nonfasting plasma total homocysteine (P-tHcy) concentration was measured in a random sample of 3...
This review presents clinical patterns that should trigger homocysteine measurement in blood, as wel...
Within-person and methodological variability of a given analyte are important elements in determinin...
Homocysteine is a sulfur-containing aminoacid produced during metabolism of methionine. Since 1969 t...